Charles Schwab Investment Management Inc. lowered its stake in Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS by 12.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 332,389 shares of the technology company's stock after selling 47,090 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.29% of Celestica worth $30,661,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Celestica in the third quarter valued at $61,210,000. Whale Rock Capital Management LLC lifted its holdings in Celestica by 13.0% in the 3rd quarter. Whale Rock Capital Management LLC now owns 8,467,244 shares of the technology company's stock valued at $432,846,000 after purchasing an additional 975,163 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Celestica by 38.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,084,722 shares of the technology company's stock worth $55,451,000 after purchasing an additional 301,563 shares during the last quarter. Natixis Advisors LLC grew its holdings in shares of Celestica by 1,697.3% during the third quarter. Natixis Advisors LLC now owns 233,485 shares of the technology company's stock worth $11,936,000 after buying an additional 220,494 shares in the last quarter. Finally, Alberta Investment Management Corp raised its position in shares of Celestica by 161.5% in the fourth quarter. Alberta Investment Management Corp now owns 279,791 shares of the technology company's stock valued at $25,808,000 after buying an additional 172,814 shares during the last quarter. Institutional investors and hedge funds own 67.38% of the company's stock.
Insiders Place Their Bets
In other news, President Todd C. Cooper sold 65,000 shares of the company's stock in a transaction on Friday, February 7th. The shares were sold at an average price of $129.78, for a total value of $8,435,700.00. Following the completion of the transaction, the president now directly owns 110,426 shares in the company, valued at approximately $14,331,086.28. This represents a 37.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Yann L. Etienvre sold 9,181 shares of Celestica stock in a transaction on Friday, January 31st. The stock was sold at an average price of $127.54, for a total transaction of $1,170,944.74. Following the sale, the insider now directly owns 83,179 shares in the company, valued at $10,608,649.66. This trade represents a 9.94 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 959,381 shares of company stock worth $119,142,019 in the last 90 days. 1.00% of the stock is owned by company insiders.
Celestica Stock Up 4.1 %
Shares of NYSE CLS traded up $3.75 on Thursday, hitting $95.67. The company had a trading volume of 3,716,795 shares, compared to its average volume of 2,729,781. The company has a quick ratio of 0.87, a current ratio of 1.47 and a debt-to-equity ratio of 0.49. Celestica Inc. has a 12-month low of $40.25 and a 12-month high of $144.27. The firm has a market capitalization of $11.13 billion, a P/E ratio of 25.65 and a beta of 2.21. The business has a 50 day moving average of $110.24 and a two-hundred day moving average of $85.74.
Analyst Ratings Changes
Several research firms have commented on CLS. Cibc World Mkts raised shares of Celestica from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 31st. Royal Bank of Canada increased their target price on Celestica from $115.00 to $140.00 and gave the stock an "outperform" rating in a research report on Friday, January 31st. UBS Group started coverage on Celestica in a report on Friday, November 22nd. They issued a "neutral" rating and a $95.00 price target for the company. Canaccord Genuity Group increased their price objective on shares of Celestica from $77.00 to $110.00 and gave the stock a "buy" rating in a report on Friday, December 20th. Finally, JPMorgan Chase & Co. assumed coverage on shares of Celestica in a report on Friday, February 21st. They issued an "overweight" rating and a $166.00 target price for the company. Two research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Celestica presently has an average rating of "Moderate Buy" and an average price target of $110.83.
View Our Latest Report on CLS
Celestica Profile
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
See Also

Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.